Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomized, Observer-blind, Placebo-controlled, Crossover Study to Assess Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age

NCT06634797 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT06634797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06634797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomized, Observer-blind, Placebo-controlled, Crossover Study to Assess Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
Lead sponsor
ModernaTX, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 8, 2024
Completion date
January 20, 2025
Enrollment
1,000 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers